Related references
Note: Only part of the references are listed.Leukotriene Signaling in Atherosclerosis and Ischemia
Magnus Back
CARDIOVASCULAR DRUGS AND THERAPY (2009)
GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4
Akiko Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury
Wei Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport
Michael P. W. Moos et al.
FASEB JOURNAL (2008)
Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors
Akiko Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends
Valerie Capra et al.
MEDICINAL RESEARCH REVIEWS (2007)
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
Paolo Ciana et al.
EMBO JOURNAL (2006)
Leukotriene modifiers as potential therapeutics for cardiovascular disease
CD Funk
NATURE REVIEWS DRUG DISCOVERY (2005)
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
A Helgadottir et al.
NATURE GENETICS (2004)
Cysteinyl leukotrienes and their receptors: (Cellular distribution and function in immune and inflammatory responses
Y Kanaoka et al.
JOURNAL OF IMMUNOLOGY (2004)
Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure
YQ Hui et al.
CIRCULATION (2004)
Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice
TC Beller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells
M Sjöström et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
R Spanbroek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2 -: Differential pharmacological properties and tissue distribution
H Ogasawara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The murine cysteinyl leukotriene 2 (CysLT2) receptor -: cDNA and genomic cloning, alternative splicing, and in vitro characterization
YQ Hui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Prostaglandins and leukotrienes: Advances in eicosanoid biology
CD Funk
SCIENCE (2001)
Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells
M Kamohara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Characterization of the human cysteinyl leukotriene 2 receptor
CE Heise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor
J Takasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Leukotrienes in caudiovascular diseases
G Folco et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
